BioSpace News Archive

Intensity Therapeutics, Inc. announced that data from its ongoing phase 1/2 clinical trial in refractory patients demonstrating the efficacy and tolerability of INT230-6, either as monotherapy or in combination with ipilimumab in patients with relapsed, refractory and metastatic sarcomas, will be presented on June 5, at the 2022 American Society of Clinical Oncology Annual Meeting being held in Chicago and virtually from June 3-7, 2022.

Immunic, Inc. reported top-line data from its phase 2 CALDOSE-1 trial of lead asset, vidofludimus calcium, the company’s selective oral DHODH inhibitor, in patients with moderate-to-severe ulcerative colitis .

LumiraDx Limited announced it has expanded its cardiovascular offering with a CE Mark for its new NT-proBNP test to aid in the diagnosis of CHF and an updated CE Mark for its D-Dimer test to now rule out venous thromboembolism in symptomatic patients.

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced that the Company will present at the following upcoming investor conferences in June.

ChromaDex Corp. announced a partnership with Juvenis to conduct cross-border sales of Tru Niagen® in South Korea.

Zomedica Corp., a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Karen DeHaan-Fullerton as its General Counsel and Corporate Secretary.

Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, will present at the 2022 Jefferies Healthcare Conference on Thursday, June 9, 2022, at 1:00 p.m. ET in New York City.

Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli.

Albany NY, United States: Cognitive disorders, also known as neurocognitive disorders, are defined as any disorder that significantly impairs the cognitive function of an individual.

Albany NY, United States: Substantial evidence of efficacy of capnography to measure the concentration of CO2 in respiratory gases to investigate several respiratory diseases is promising for the demand of capnography devices.